274 related articles for article (PubMed ID: 26216987)
41. Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade.
Huang L; Kinnucan E; Wang G; Beaudenon S; Howley PM; Huibregtse JM; Pavletich NP
Science; 1999 Nov; 286(5443):1321-6. PubMed ID: 10558980
[TBL] [Abstract][Full Text] [Related]
42. Cobalamins Function as Allosteric Activators of an Angelman Syndrome-Associated UBE3A/E6AP Variant.
Müller F; Jansen J; Offensperger F; Eichbichler D; Stengel F; Scheffner M
Chembiochem; 2024 May; 25(10):e202400184. PubMed ID: 38573110
[TBL] [Abstract][Full Text] [Related]
43. Orthogonal ubiquitin transfer reveals human papillomavirus E6 downregulates nuclear transport to disarm interferon-γ dependent apoptosis of cervical cancer cells.
Wang Y; Liu R; Liao J; Jiang L; Jeong GH; Zhou L; Polite M; Duong D; Seyfried NT; Wang H; Kiyokawa H; Yin J
FASEB J; 2021 Nov; 35(11):e21986. PubMed ID: 34662469
[TBL] [Abstract][Full Text] [Related]
44. Regulation of O-Linked N-Acetyl Glucosamine Transferase (OGT) through E6 Stimulation of the Ubiquitin Ligase Activity of E6AP.
Peng K; Liu R; Jia C; Wang Y; Jeong GH; Zhou L; Hu R; Kiyokawa H; Yin J; Zhao B
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638625
[TBL] [Abstract][Full Text] [Related]
45. Crystal structure of the catalytic C-lobe of the HECT-type ubiquitin ligase E6AP.
Ries LK; Liess AKL; Feiler CG; Spratt DE; Lowe ED; Lorenz S
Protein Sci; 2020 Jun; 29(6):1550-1554. PubMed ID: 31994269
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation.
Jeong KW; Kim HZ; Kim S; Kim YS; Choe J
Oncogene; 2007 Jan; 26(4):487-99. PubMed ID: 16878151
[TBL] [Abstract][Full Text] [Related]
47. GRIM-19 disrupts E6/E6AP complex to rescue p53 and induce apoptosis in cervical cancers.
Zhou Y; Wei Y; Zhu J; Wang Q; Bao L; Ma Y; Chen Y; Feng D; Zhang A; Sun J; Nallar SC; Shen K; Kalvakolanu DV; Xiao W; Ling B
PLoS One; 2011; 6(7):e22065. PubMed ID: 21765936
[TBL] [Abstract][Full Text] [Related]
48. Deciphering the mechanisms of HPV E6 mutations in the destabilization of E6/E6AP/p53 complex.
Li L; Dong X; Tang Y; Lao Z; Li X; Lei J; Wei G
Biophys J; 2022 May; 121(9):1704-1714. PubMed ID: 35364103
[TBL] [Abstract][Full Text] [Related]
49. Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53.
Zanier K; ould M'hamed ould Sidi A; Boulade-Ladame C; Rybin V; Chappelle A; Atkinson A; Kieffer B; Travé G
Structure; 2012 Apr; 20(4):604-17. PubMed ID: 22483108
[TBL] [Abstract][Full Text] [Related]
50. Loss of Angelman Syndrome Protein E6AP Disrupts a Novel Antagonistic Estrogen-Retinoic Acid Transcriptional Crosstalk in Neurons.
El Hokayem J; Weeber E; Nawaz Z
Mol Neurobiol; 2018 Sep; 55(9):7187-7200. PubMed ID: 29388081
[TBL] [Abstract][Full Text] [Related]
51. Sequence determinants of E2-E6AP binding affinity and specificity.
Eletr ZM; Kuhlman B
J Mol Biol; 2007 Jun; 369(2):419-28. PubMed ID: 17433363
[TBL] [Abstract][Full Text] [Related]
52. Physical and functional interaction of the HECT ubiquitin-protein ligases E6AP and HERC2.
Kühnle S; Kogel U; Glockzin S; Marquardt A; Ciechanover A; Matentzoglu K; Scheffner M
J Biol Chem; 2011 Jun; 286(22):19410-6. PubMed ID: 21493713
[TBL] [Abstract][Full Text] [Related]
53. Catalytically Important Residues of E6AP Ubiquitin Ligase Identified Using Acid-Cleavable Photo-Cross-Linkers.
Krist DT; Statsyuk AV
Biochemistry; 2015 Jul; 54(29):4411-4. PubMed ID: 26161728
[TBL] [Abstract][Full Text] [Related]
54. Differential localization of HPV16 E6 splice products with E6-associated protein.
Vaeteewoottacharn K; Chamutpong S; Ponglikitmongkol M; Angeletti PC
Virol J; 2005 Jun; 2():50. PubMed ID: 15960845
[TBL] [Abstract][Full Text] [Related]
55. Activation of E6AP/UBE3A-Mediated Protein Ubiquitination and Degradation Pathways by a Cyclic γ-AA Peptide.
Huang B; Zhou L; Liu R; Wang L; Xue S; Shi Y; Jeong GH; Jeong IH; Li S; Yin J; Cai J
J Med Chem; 2022 Feb; 65(3):2497-2506. PubMed ID: 35045253
[TBL] [Abstract][Full Text] [Related]
56. Interaction of HPV E6 oncoproteins with specific proteasomal subunits.
Tomaić V; Ganti K; Pim D; Bauer C; Blattner C; Banks L
Virology; 2013 Nov; 446(1-2):389-96. PubMed ID: 24074603
[TBL] [Abstract][Full Text] [Related]
57. Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome.
Tomaić V; Banks L
Cell Death Dis; 2015 Jan; 6(1):e1625. PubMed ID: 25633294
[TBL] [Abstract][Full Text] [Related]
58. Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP.
Be X; Hong Y; Wei J; Androphy EJ; Chen JJ; Baleja JD
Biochemistry; 2001 Feb; 40(5):1293-9. PubMed ID: 11170455
[TBL] [Abstract][Full Text] [Related]
59. E6AP/UBE3A catalyzes encephalomyocarditis virus 3C protease polyubiquitylation and promotes its concentration reduction in virus-infected cells.
Carmody M; Notarianni TP; Sambel LA; Walsh SJ; Burke JM; Armstrong JL; Lawson TG
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):63-69. PubMed ID: 29054411
[TBL] [Abstract][Full Text] [Related]
60. A small-molecule inhibitor of MDMX suppresses cervical cancer cells via the inhibition of E6-E6AP-p53 axis.
Zhang J; Yu G; Yang Y; Wang Y; Guo M; Yin Q; Yan C; Tian J; Fu F; Wang H
Pharmacol Res; 2022 Mar; 177():106128. PubMed ID: 35150860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
